Business Merck and Moderna Announce Landmark Phase 3 Success for Personalized mRNA Melanoma Cancer Vaccine August 19, 2026 • RAHWAY, N.J. & CAMBRIDGE, Mass. — In a historic milestone for oncology and mRNA technology,...